.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Healthtrust
McKesson
US Army
Mallinckrodt
Novartis
Accenture
Boehringer Ingelheim
Citi
Julphar

Generated: June 28, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090121

« Back to Dashboard
NDA 090121 describes FINASTERIDE, which is a drug marketed by Zydus Pharms Usa Inc, Alkem Labs Ltd, Teva, Sun Pharma Global, Actavis Totowa Teva, Accord Hlthcare, Cipla Ltd, Dr Reddys Labs Inc, Dr Reddys Labs Ltd, Ivax Sub Teva Pharms, Aurobindo Pharma, Gedeon Richter Usa, Hetero Labs Ltd Iii, Mylan Pharms Inc, Actavis Totowa, Mylan, and Aurobindo Pharma Ltd, and is included in twenty-two NDAs. It is available from thirty-nine suppliers. Additional details are available on the FINASTERIDE profile page.

The generic ingredient in FINASTERIDE is finasteride. There are fourteen drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the finasteride profile page.

Summary for NDA: 090121

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Genitourinary Agents
Hormonal Agents, Suppressant (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details

Pharmacology for NDA: 090121

Mechanism of Action5-alpha Reductase Inhibitors

Suppliers and Packaging for NDA: 090121

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FINASTERIDE
finasteride
TABLET;ORAL 090121 ANDA Accord Healthcare, Inc. 16729-090 16729-090-01 100 TABLET, FILM COATED in 1 BOTTLE (16729-090-01)
FINASTERIDE
finasteride
TABLET;ORAL 090121 ANDA Accord Healthcare, Inc. 16729-090 16729-090-10 30 TABLET, FILM COATED in 1 BOTTLE (16729-090-10)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Feb 23, 2010TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Fish and Richardson
Johnson and Johnson
Cantor Fitzgerald
McKesson
Argus Health
Citi
Queensland Health
Chinese Patent Office
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot